Globus Medical: Obtaining My Backing Again
Globus Medical is experiencing significant growth, with a 27% increase in Q1 sales and a 13% rise in base revenues. The company has also raised its full-year EPS guidance by $0.30, indicating strong operational performance. Current share valuations present an attractive entry point for investors as fundamentals remain solid.
- ▪Globus Medical reported a 27% increase in Q1 sales and a 13% rise in base revenues.
- ▪The company raised its full-year EPS guidance by $0.30 to a range of $4.70 to $4.80.
- ▪Shares are currently trading at 16–17 times earnings, with net cash of $800 million.
Seeking Alpha files mainly under finance. We currently carry 6,426 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4911252-globus-medical-obtaining-my-backing-again"},"author":{"@type":"Person","name":"The Value Investor","url":"https://seekingalpha.com/author/the-value-investor"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
